BVTV: Biogen’s Alzheimer’s drug might exceed Wall Street expectations

BVTV: Biogen’s Alzheimer’s drug might exceed Wall Street expectations

Biogen’s market value rose $11 bln on news its new treatment for Alzheimer’s disease appeared effective. Robert Cyran explains why this rise is rather cautious, and how the drug might exceed Wall Street’s assumptions.

#Biogen #Alzheimer #Business #News #Reuters #newsfeed

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

source

Click for the latest news…